Phase I study of pazopanib plus TH-302 in advanced solid tumors.
Riedel RF, Meadows KL, Lee PH, Morse MA, Uronis HE, Blobe GC, George DJ, Crawford J, Niedzwiecki D, Rushing CN, Arrowood CC, Hurwitz HI.
Riedel RF, et al. Among authors: morse ma.
Cancer Chemother Pharmacol. 2017 Mar;79(3):611-619. doi: 10.1007/s00280-017-3256-2. Epub 2017 Feb 25.
Cancer Chemother Pharmacol. 2017.
PMID: 28238078
Clinical Trial.